Create an alert
to follow the executive moves at CTI BioPharma.
Merck has announced the acquisition of ArQule (posted on Dec 9, 2019).
Astellas Pharma has announced the acquisition of Audentes Therapeutics (posted on Dec 5, 2019).
Mesa Laboratories has announced the acquisition of Gyros (posted on Nov 1, 2019).
CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Benefit in Myelofibrosis Patients with Severe Thrombocytopenia at the 61st American Society of Hematology Meeting | CTI BioPharma Corp.
CTI BioPharma Announces Presentations at the 61st American Society of Hematology Meeting | CTI BioPharma Corp.
CTI BioPharma Reports Third Quarter 2019 Financial Results | CTI BioPharma Corp.
CTI BioPharma Begins Patient Enrollment in PACIFICA Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis Patients With Severe Thrombocytopenia | CTI BioPharma Corp.
CTI BioPharma has 3 subsidiaries including Aequus BioPharma, Aequus Pharma and CTI Life Sciences. CTI BioPharma has 1,320 competitors including Alltech (United States (USA)), Aldeyra Therapeutics (United States (USA)) and Charles River Laboratories International (United States (USA)).
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.